AUROPHARMA.NSE Aurobindo Pharma Ltd.

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Aurobindo Pharma Ltd. market cap is 653.5B.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Aurobindo Pharma Ltd. 52 week high is 1,177.10 as of May 10, 2024.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Aurobindo Pharma Ltd. 52 week low is 581.25 as of May 10, 2024.

Aurobindo Pharma Ltd. stock price today is 1,113.00.

Aurobindo Pharma Ltd. stock price yesterday was 1,131.20.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Aurobindo Pharma Ltd.’s P/E ratio is 23.59.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Aurobindo Pharma Ltd. P/B ratio is 2.3183.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Aurobindo Pharma Ltd.'s EBITDA is 10.29.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Aurobindo Pharma Ltd. 50-day moving average is 1,084.22.

Aurobindo Pharma Ltd. has 33,413 employees.